Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier

References

• Begona CG, Ruth D. Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int J Pharm 1997; 148: 231–240
   Google Scholar
• Cai Q, Zhang ZR. Lectin-mediated cytotoxicity and specificity of 5-fluorouracil conjugated with peanut agglutinin (5-Fu-PNA) in vitro. J Drug Target 2005; 13(4)251–257
   PubMed Web of Science ®Google Scholar
• Czock D, Keller F, Rasche FM, Haussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 2005; 44(1)61–98
   PubMed Web of Science ®Google Scholar
• Eaton DC, Pooler J. Renal blood flow and glomerular filtration. Lange medical books: Vander's renal physiology6th ed., AJ Vander, LG Navar. McGraw Hill, New York 2004; 24–37
   Google Scholar
• Ekrami H, Kennedy AR, Shen WC. Disposition of positively charged bowman-brik ptoease inhibitor conjugates in mice-influence of protein conjugate charge-density and size on lung targeting. J Pharm Sci 1995; 84(4)456–461
   PubMed Web of Science ®Google Scholar
• Hudecz F, Remenyi J, Szabo R, Kocan G, Mezo G, Kovacs P, Gaal D. Drug targeting by macromolecules without recognition unit?. J Mol Recognit 2003; 16: 288–298
   PubMed Web of Science ®Google Scholar
• Folgert R, Haverdings G, Haas M, Greupink AR, Marcel de Vries P, Moolenaar F, Zeeuw D, Meijer DKF. Potentials and limitations of the low molecular-weight protein lysozyme as a carrier for renal drug targeting. Renal Failure 2001; 23: 397–409
   PubMed Web of Science ®Google Scholar
• Friedman AL, Chesney RW. Glucocorticoids in renal disease: Theoretical basis, consequences and efficacy of use in the pediatric patient. Am J Nephrol 1982; 2(6)330–341
   PubMed Web of Science ®Google Scholar
• Gupta KC, Kumar MNVR. Drug release behavior of beads and microgranules of chitosan. Biomaterials 2000; 20: 1115–1119
   Google Scholar
• Haas M, De Zeeuw D, Van Zanten A, Meijer DKF. Quantification of renal low-molecular-weight protein handling in the intact rat. Kidney Int 1993; 43: 949–954
   PubMed Web of Science ®Google Scholar
• Haas M, Meijer DKF, De Zeeuw D. Specific drug delivery to the kidney. Cardiovas Drug Ther 2002; 16: 489–496
   PubMed Web of Science ®Google Scholar
• Haga HJ. Kidney lysosomes. Int J Biochem 1989; 21: 343–345
   PubMedGoogle Scholar
• Kamada H, Tsutsumi Y, Kamada KS, Yamamoto Y, Yasuo Y, Okamoto T, Nakagawa S, Nagata S, Mayumi T. Synthesis of a poly (vinylpyrrolidone- co-dimethyl maleic anhydride) co-polymer and its application as renal targeting carrier. Nat Biotechnol 2003; 21: 399–404
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Tsutsumi Y, Yoshioka Y, Kamada H, Yamamoto Y, Kodaira H, Tsunoda S, Okamoto T, Mukai Y, Shibata H, Nakagawa S, Mayumi T. The use of PVP as a polymeric carrier to improve the plasma half-life of drugs. Biomaterials 2004; 25: 3259–3266
   PubMed Web of Science ®Google Scholar
• Kodaira H, Tsutsumi Y, Yoshioka Y, Kamada H, Kaneda Y, Yamamoto Y, Tsunoda S, Okamoto T, Mukai Y, Shibata H, Nakagawa S, Mayumi T. The targeting of anionized polyvinylpyrrolidone to the renal system. Biomaterials 2004; 25(18)4309–4315
   PubMed Web of Science ®Google Scholar
• Kok RJ, Grijpstra F, Walthuis RB, Moolenaar F, De Zeeuw D, Meijer DKF. Specific delivery of captopril to the kidney with the prodrug captopril-lysozyme. J Pharmacol Exp Ther 1999; 288: 281–285
   PubMed Web of Science ®Google Scholar
• Kubota N, Eguchi Y. Facile preparation of water-soluble N-acetylated chitosan and molecular weight dependence of its water-solubility. Polym J 1997; 29(2)123–127
   Web of Science ®Google Scholar
• Kubota N, Tatsumoto N, Sano T, Toya K. A simple preparation of half N-acetylated chitosan highly soluble in water and aqueous organic solvents. Carbohyd Res 2000; 324: 268–274
   PubMed Web of Science ®Google Scholar
• Kurita K, Koyama Y, Nishimura S, Kamiya M. Facile preparation of water-soluble chitin from chitosan. Chem Lett 1989; 9: 1597–1598
   Google Scholar
• Lee KY, Ha WS, Park WH. Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. Biomaterials 1995; 16: 1211–1216
   PubMed Web of Science ®Google Scholar
• Licha K, Olbrich C. Optical imaging in drug discovery and diagnostic applications. Adv Drug Delivery Rev 2005; 57: 1087–1108
   PubMed Web of Science ®Google Scholar
• Magee MH, Blum RA, Lates CD, Jusko WJ. Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race. J Clin Pharm 2001; 41(11)1180–1194
   PubMed Web of Science ®Google Scholar
• Mehvar R, Robinson MA, Reynolds JM. Molecular weight dependent tissue accumulation of dextrans: In vivo studies in rats. J Pharm Sci 1994; 83(10)1495–1499
   PubMed Web of Science ®Google Scholar
• Moleod AD, Friend DR, Tozer TN. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: Hydrolysis in Rat gastrointestinal tract contents. J Pharm Sci 1994; 83(9)1284–1288
   PubMed Web of Science ®Google Scholar
• Okamoto T, Nakagawa S, Tsutsumi Y. The optimal molecular design of polymeric drug carriers and its application for renal drug targeting. Gene Ther Mol Biol 2004; 8: 221–230
   Google Scholar
• Onishi H, Machida Y. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 1999; 20: 175–182
   PubMed Web of Science ®Google Scholar
• Pinaud F, Michalet X, Bentolila LA, Tsay JM, Doose S, Li JJ, Iyer G, Weiss S. Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials 2006; 27(9)1679–1687
   PubMed Web of Science ®Google Scholar
• Qin CQ, Du YM, Xiao L. Effect of hydrogen peroxide treatment on the molecular weight and structure of chitosan. Polym Degrad Stabil 2002; 76: 211–218
   Web of Science ®Google Scholar
• Rohatagi S, Barth J, Mollmann H, Hochhau SG, Soldner A, Mollmann C, Derendorf H. Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration. J Clin Pharm 1997; 37(10)916–925
   PubMed Web of Science ®Google Scholar
• Sannan T, Kurita K, Iwakura Y. Studies on chitin 2: Effect of deacetylation on solubility. Makromolekulare Chemie 1976; 177(12)3589–3600
   Web of Science ®Google Scholar
• Suntres ZE, Shek PN. Liposomes promote pulmonary glucocorticoid delivery. J Drug Target 1998; 6(3)175–182
   PubMed Web of Science ®Google Scholar
• Suzuki K, Susaki H, Okuno S, Sugiyama Y. Renal drug targeting using a vector “alkylglycoside”. J Pharmacol Exp Ther 1999a; 288(1)57–64
   PubMed Web of Science ®Google Scholar
• Suzuki K, Susaki H, Okuno S, Yamada H, Watanabe HK, Sugiyama Y. Specific renal delivery of sugar modified low-molecular-weight peptides. J Pharmacol Exp Ther 1999b; 288(2)888–897
   PubMed Web of Science ®Google Scholar
• Wilk S, Mizoguchi H, Orlowski M. γ-Glutamyl dopa: A kidney-specific dopamine precursor. J Pharmacol Exp Ther 1978; 206(1)227–232
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Tsutsumi Y, Yoshioka Y, Kamada H, Kamada KS, Okamoto T, Mukai Y, Shibata H, Nakagawa S, Mayumi T. Poly (vinylpyrrolidone-co- dimethylmaleic acid) as a novel renal targeting carrier. J Control Release 2004; 95(2)229–237
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhang PY, Yang YM, Wang XD, Gu XS. The interaction of Schwann cells with chitosan membranes and fibers in vitro. Biomaterials 2004; 25(18)4273–4278
   PubMed Web of Science ®Google Scholar